Causas urinarias y ginecológicas | 02 NOV 17

Diagnóstico y manejo del dolor anorrectal y pélvico

Pruebas epidemiológicas, historia natural, fisiopatología, diagnóstico y manejo del dolor anorrectal y pélvico
Autor/a: Adil E. Bharucha, Tae Hee Lee. Mayo Clin Proc. n October 2016;91(10):1471-1486
INDICE:  1. Página 1 | 2. Página 2
Página 2

Referencias

1. Clemens JQ. Male and female pelvic pain disordersdis it all in their heads? [editorial]. J Urol. 2008;179(3):813-814.

2. Potts JM, Payne CK. Urologic chronic pelvic pain. Pain. 2012;153(4):755-758.

3. Bharucha AE, Trabuco E. Functional and chronic anorectal and pelvic pain disorders. Gastroenterol Clin North Am. 2008; 37(3):685-696.

4. Rao SS, Bharucha AE, Chiarioni G, et al. Anorectal disorders. Gastroenterology. 2016;150(6):1430-1442.e4.

5. Hanno PM, Erickson D, Moldwin R, Faraday MM. Diagnosis and treatment of interstitial cystitis/bladder pain syndrome: AUA guideline amendment. J Urol. 2015;193(5):1545-1553.

6. Rees J, Abrahams M, Doble A, Cooper A; Prostatitis Expert Reference Group (PERG). Diagnosis and treatment of chronic bacterial prostatitis and chronic prostatitis/chronic pelvic pain syndrome: a consensus guideline. BJU Int. 2015;116(4):509-525.

7. Grant SR, Salvati EP, Rubin RJ. Levator syndrome: an analysis of 316 cases. Dis Colon Rectum. 1975;18(2):161-163.

8. Barry MJ, Fowler FJ Jr, O’Leary MP, et al; Measurement Committee of the American Urological Association. The American Urological Association symptom index for benign prostatic hyperplasia. J Urol. 1992;148(5):1549-1557.

9. Litwin MS, McNaughton-Collins M, Fowler FJ Jr, et al; Chronic Prostatitis Collaborative Research Network. The National Institutes of Health Chronic Prostatitis Symptom Index: development and validation of a new outcome measure. J Urol. 1999;162(2):369-375.

10. Cam K. BPH: How useful is a visual prostate symptom score for patients? Nature Reviews Urology. 2011;8(10):536-537.

11. Shoskes DA, Nickel JC, Rackley RR, Pontari MA. Clinical phenotyping in chronic prostatitis/chronic pelvic pain syndrome and interstitial cystitis: a management strategy for urologic chronic pelvic pain syndromes. Prostate Cancer Prostatic Dis. 2009;12(2):177-183.

12. O’Leary MP, Sant GR, Fowler FJ Jr, Whitmore KE, Spolarich- Kroll J. The interstitial cystitis symptom index and problem index. Urology. 1997;49(5A, suppl):58-63.

13. Rao SS, Bharucha AE, Chiarioni G, et al. Functional anorectal disorders. Gastroenterology. 2016;150:1430-1442.

14. Kroenke K, Spitzer RL, Williams JB. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med. 2001; 16(9):606-613.

15. Spitzer RL, Kroenke K, Williams JB, Löwe B. A brief measure for assessing generalized anxiety disorder: the GAD-7. Arch Intern Med. 2006;166(10):1092-1097.

16. Drossman DA, Li Z, Andruzzi E, et al. U.S. householder survey of functional gastrointestinal disorders: prevalence, sociodemography, and health impact. Dig Dis Sci. 1993;38(9):1569-1580.

17. Grimaud JC, Bouvier M, Naudy B, Guien C, Salducci J. Manometric and radiologic investigations and biofeedback treatment of chronic idiopathic anal pain. Dis Colon Rectum. 1991;34(8):690-695.

18. Chiarioni G, Nardo A, Vantini I, Romito A, Whitehead WE. Biofeedback is superior to electrogalvanic stimulation and massage for treatment of levator ani syndrome. Gastroenterology. 2010;138(4):1321-1329.

19. Harvey RF. Colonic motility in proctalgia fugax. Lancet. 1979; 2(8145):713-714.

20. Eckardt VF, Dodt O, Kanzler G, Bernhard G. Anorectal function and morphology in patients with sporadic proctalgia fugax. Dis Colon Rectum. 1996;39(7):755-762.

21. Rao SS, Hatfield RA. Paroxysmal anal hyperkinesis: a characteristic feature of proctalgia fugax. Gut. 1996;39(4): 609-612.

22. Celik AF, Katsinelos P, Read W, Khan MI, Donnelly TC. Hereditary proctalgia fugax and constipation: report of a second family. Gut. 1995;36(4):581-584.

23. Heymen S, Wexner SD, Gulledge AD. MMPI assessment of patients with functional bowel disorders. Dis Colon Rectum. 1993;36(6):593-596.

24. de Parades V, Etienney I, Bauer P, Taouk M, Atienza P. Proctalgia fugax: demographic and clinical characteristics; what every doctor should know from a prospective study of 54 patients. Dis Colon Rectum. 2007;50(6):893-898.

25. Karras JD, Angelo G. Proctalgia fugax: clinical observations and a new diagnostic aid. Dis Colon Rectum. 1963;6:130-134.

26. Thompson WG. Proctalgia fugax in patients with the irritable bowel, peptic ulcer, or inflammatory bowel disease. Am J Gastroenterol. 1984;79(6):450-452.

27. Bharucha AE, Wald AM. Anorectal disorders. Am J Gastroenterol. 2010;105(4):786-794.

28. Wald A, Bharucha AE, Cosman BC, Whitehead WE. ACG clinical guideline: management of benign anorectal disorders. Am J Gastroenterol. 2014;109(8):1141-1157.

29. Bharucha AE, Fletcher JG, Seide B, Riederer SJ, Zinsmeister AR. Phenotypic variation in functional disorders of defecation. Gastroenterology. 2005;128(5):1199-1210.

30. Hompes R, Jones OM, Cunningham C, Lindsey I. What causes chronic idiopathic perineal pain? Colorectal Dis. 2011;13(9): 1035-1039.

31. Dwarkasing RS, Schouten WR, Geeraedts TE, Mitalas LE, Hop WC, Krestin GP. Chronic anal and perianal pain resolved with MRI. AJR Am J Roentgenol. 2013;200(5):1034-1041.

32. Rao SSC, Paulson J, Mata M, Zimmerman B. Clinical trial: effects of botulinum toxin on levator ani syndromeda double-blind, placebo-controlled study. Aliment Pharmacol Ther. 2009;29(9):985-991.

33. Dodi G, Bogoni F, Infantino A, Pianon P, Mortellaro LM, Lise M. Hot or cold in anal pain? a study of the changes in internal anal sphincter pressure profiles. Dis Colon Rectum. 1986; 29(4):248-251.

34. Atkin GK, Suliman A, Vaizey CJ. Patient characteristics and treatment outcome in functional anorectal pain. Dis Colon Rectum. 2011;54(7):870-875.

35. Falletto E, Masin A, Lolli P, et al; GINS (Italian Group for Sacral Neuromodulation). Is sacral nerve stimulation an effective treatment for chronic idiopathic anal pain? Dis Colon Rectum. 2009;52(3):456-462.

36. Govaert B, Melenhorst J, van Kleef M, van Gemert WG, Baeten CG. Sacral neuromodulation for the treatment of chronic functional anorectal pain: a single center experience. Pain Pract. 2010;10(1):49-53.

37. Dudding TC, Thomas GP, Hollingshead JR, George AT, Stern J, Vaizey CJ. Sacral nerve stimulation: an effective treatment for chronic functional anal pain? Colorectal Dis. 2013;15(9):1140-1144.

38. Rome JD, Sletten CD, Bruce BK. A rehabilitation approach to chronic pain in rheumatologic practice. Curr Opin Rheumatol. 1996;8(2):163-168.

39. Rome JD, Townsend CO, Bruce BK, Sletten CD, Luedtke CA, Hodgson JE. Chronic noncancer pain rehabilitation with opioid withdrawal: comparison of treatment outcomes based on opioid use status at admission. Mayo Clin Proc. 2004;79(6):759-768.

40. Eckardt VF, Dodt O, Kanzler G, Bernhard G. Treatment of proctalgia fugax with salbutamol inhalation. Am J Gastroenterol. 1996;91(4):686-689.

41. Nickel JC, Downey J, Hunter D, Clark J. Prevalence of prostatitis-like symptoms in a population based study using the National Institutes of Health chronic prostatitis symptom index. J Urol. 2001;165(3):842-845.

42. Roberts RO, Jacobson DJ, Girman CJ, Rhodes T, Lieber MM, Jacobsen SJ. Low agreement between previous physician diagnosed prostatitis and National Institutes of Health Chronic Prostatitis Symptom Index pain measures. J Urol. 2004;171(1):279-283.

43. Collins MM, Stafford RS, O’Leary MP, Barry M. How common is prostatitis? A national survey of physician visits. J Urol. 1998;159:1224-1228.

44. Wolcott RD, Ehrlich GD. Biofilms and chronic infections. JAMA. 2008;299(22):2682-2684.

45. Nickel JC, Stephens A, Landis JR, et al; MAPP Research Network. Search for microorganisms in men with urologic chronic pelvic pain syndrome: a culture-independent analysis in the MAPP Research Network. J Urol. 2015;194(1):127-135.

46. Pontari M, Giusto L. New developments in the diagnosis and treatment of chronic prostatitis/chronic pelvic pain syndrome. Curr Opin Urol. 2013;23(6):565-569.

47. True LD, Berger RE, Rothman I, Ross SO, Krieger JN. Prostate histopathology and the chronic prostatitis/chronic pelvic pain syndrome: a prospective biopsy study. J Urol. 1999;162(6):2014-2018.

48. Nickel JC, Roehrborn CG, O’Leary MP, Bostwick DG, Somerville MC, Rittmaster RS. The relationship between prostate inflammation and lower urinary tract symptoms: examination of baseline data from the REDUCE trial. Eur Urol. 2008;54(6):1379-1384.

49. Watanabe T, Inoue M, Sasaki K, et al. Nerve growth factor level in the prostatic fluid of patients with chronic prostatitis/ chronic pelvic pain syndrome is correlated with symptom severity and response to treatment. BJU Int. 2011;108(2):248-251.

50. Done JD, Rudick CN, Quick ML, Schaeffer AJ, Thumbikat P. Role of mast cells in male chronic pelvic pain. J Urol. 2012; 187(4):1473-1482.

51. Pontari MA, Ruggieri MR. Mechanisms in prostatitis/chronic pelvic pain syndrome. J Urol. 2008;179(5, suppl):S61-S67.

 

52. Mehik A, Hellström P, Sarpola A, Lukkarinen O, Järvelin MR. Fears, sexual disturbances and personality features in men with prostatitis: a population-based cross-sectional study in Finland. BJU Int. 2001;88(1):35-38.

53. Anderson RU, Orenberg EK, Chan CA, Morey A, Flores V. Psychometric profiles and hypothalamic-pituitary-adrenal axis function in men with chronic prostatitis/chronic pelvic pain syndrome. J Urol. 2008;179(3):956-960.

54. Chen X, Zhou Z, Qiu X, Wang B, Dai J. The effect of chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS) on erectile function: a systematic review and meta-analysis. PLoS One. 2015;10(10):e0141447.

55. Naliboff BD, Stephens AJ, Afari N, et al; MAPP Research Network. Widespread psychosocial difficulties in men and women with urologic chronic pelvic pain syndromes: casecontrol findings from the Multidisciplinary Approach to the Study of Chronic Pelvic Pain Research Network. Urology. 2015;85(6):1319-1327.

56. Wenninger K, Heiman JR, Rothman I, Berghuis JP, Berger RE. Sickness impact of chronic nonbacterial prostatitis and its correlates. J Urol. 1996;155(3):965-968.

57. Pontari MA, McNaughton-Collins M, O’Leary MP, et al; CPCRN Study Group. A case-control study of risk factors in men with chronic pelvic pain syndrome. BJU Int. 2005;96(4):559-565.

58. Nickel JC, Shoskes D, Wang Y, et al. How does the premassage and post-massage 2-glass test compare to the Meares-Stamey 4-glass test in men with chronic prostatitis/chronic pelvic pain syndrome? J Urol. 2006;176(1):119-124.

59. Moghaddasi M, Aghaii M, Mamarabadi M. Perianal pain as a presentation of lumbosacral neurofibroma: a case report. J Neurol Surg Rep. 2014;75(2):e191-e193.

60. Elist J. Effects of pollen extract preparation Prostat/Poltit on lower urinary tract symptoms in patients with chronic nonbacterial prostatitis/chronic pelvic pain syndrome: a randomized, double-blind, placebo-controlled study. Urology. 2006;67(1):60-63.

61. Zhao WP, Zhang ZG, Li XD, et al. Celecoxib reduces symptoms in men with difficult chronic pelvic pain syndrome (category IIIA). Braz J Med Biol Res. 2009;42(10):963-967.

62. Pontari MA, Krieger JN, Litwin MS, et al; Chronic Prostatitis Collaborative Research Network-2. Pregabalin for the treatment of men with chronic prostatitis/chronic pelvic pain syndrome: a randomized controlled trial. Arch Intern Med. 2010; 170(17):1586-1593.

63. Kaplan SA, Volpe MA, Te AE. A prospective, 1-year trial using saw palmetto versus finasteride in the treatment of category III prostatitis/chronic pelvic pain syndrome. J Urol. 2004;171(1):284-288.

 

Comentarios

Para ver los comentarios de sus colegas o para expresar su opinión debe ingresar con su cuenta de IntraMed.

AAIP RNBD
Términos y condiciones de uso | Todos los derechos reservados | Copyright 1997-2022